Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress

Oxid Med Cell Longev. 2008 Oct-Dec;1(1):54-62. doi: 10.4161/oxim.1.1.6958.

Abstract

Oxidative stress is regarded as a mediator of nerve cell death in several neurodegenerative disorders, such as Parkinson's disease. Sesamin, a lignan mainly found in sesame oil, is currently under study for its anti-oxidative and possible neuroprotective properties. We used 1-methyl-4-phenyl-pyridine (MPP(+)) ion, the active metabolite of the potent parkinsonism-causing toxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, to produce oxidative stress and neurodegeneration in neuronal PC12 cells, which express dopamine, as well as neurofilaments. Our results show that picomolar doses of sesamin protected neuronal PC12 cells from MPP(+)-induced cellular death, as revealed by colorimetric measurements and production of reactive oxygen species. We also demonstrated that sesamin acted by rescuing tyrosine hydroxylase levels from MPP(+)-induced depletion. Sesamin, however, did not modulate dopamine transporter levels, and estrogen receptor-alpha and -beta protein expression. By examining several parameters of cell distress, we found that sesamin also elicited a strong increase in superoxide dismutase activity as well as protein expression and decreased catalase activity and the MPP(+) stimulated inducible nitric oxide synthase protein expression, in neuronal PC12 cells. Finally, sesamin possessed significant anti-inflammatory properties, as disclosed by its potential to reduce MPP(+)-induced interleukin-6 mRNA levels in microglia. From these studies, we determined the importance of the lignan sesamin as a neuroprotective molecule and its possible role in complementary and/or preventive therapies of neurodegenerative diseases.

Keywords: MPP+; Parkinson's disease; dopamine; lignans; neurodegeneration; neuroinflammation; neuroprotection; oxidative stress; protein expression; sesamin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / pharmacology
  • Animals
  • Antioxidants / pharmacology
  • Catalase / biosynthesis*
  • Catalase / metabolism
  • Dioxoles / pharmacology*
  • Dopamine / metabolism
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / metabolism
  • Lignans / pharmacology*
  • Neurons / drug effects
  • Neurons / enzymology
  • Neurons / metabolism
  • Nitric Oxide Synthase Type II / biosynthesis*
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology*
  • PC12 Cells
  • Rats
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / biosynthesis*
  • Superoxide Dismutase / metabolism
  • Tyrosine 3-Monooxygenase / biosynthesis*
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Antioxidants
  • Dioxoles
  • Dopamine Plasma Membrane Transport Proteins
  • Interleukin-6
  • Lignans
  • Reactive Oxygen Species
  • Catalase
  • Nitric Oxide Synthase Type II
  • Tyrosine 3-Monooxygenase
  • Superoxide Dismutase
  • 1-Methyl-4-phenylpyridinium
  • sesamin
  • Dopamine